News and Trends 20 Sep 2016 This company just turned the lights ON for NanoMed Bioplastic Bio-ON just patented the first application of bioplastic in nanomedicine with a diagnostic tool for cancer that will grant it access to a whole new market previously inaccessible to this industry. Italy-based Bio-ON is trying to change the world by producing alternative sustainable chemicals and bioplastic materials with industrial applications. Their newest product, minerv BIOMEDS, will be used […] September 20, 2016 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 20 Sep 2016 UPDATE: Novartis is Favoured to Win the Race for a New MS Drug Novartis is poised to kick off the next generation of multiple sclerosis treatments after siponimod performs well in Phase III. The company’s primary competitor had been Biogen, but its drug’s failure in Phase II leaves siponimod the last man standing. Novartis reports that its multiple sclerosis (MS) drug, siponimod, has reached its primary endpoint in Phase III […] September 20, 2016 - 2 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 20 Sep 2016 Genfit’s Non-Invasive Diagnostic could unlock the NASH Market Genfit reinforced its leading place in the race to find a cure for NASH when it announced this morning the launch of a program to validate their new diagnostic tool. Genfit is already leading in the development of a cure for Non-Alcoholic Stato-Hepatitis (NASH) with its candidate, Elafibranor, which is in Phase III trials. Now, the French €600M biopharma has […] September 20, 2016 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 20 Sep 2016 This European Biotech Initiative wants to remediate Contaminated Land It has been estimated that the impact of potentially polluting activities has affected around 3 million sites in Europe alone with great risk of adverse human health effects. As a result, there is considerable pressure to develop new innovative and cost-effective solutions to the problems posed by pollution. REMEDIATE ITN is making its approach. The project […] September 20, 2016 - 5 minutesmins - By Joachim Eeckhout Share WhatsApp Twitter Linkedin Email
News and Trends 19 Sep 2016 Italian Gene Therapy Biotech aims high by Collaborating with US Giant Amgen Genenta Science and Amgen have teamed up to develop gene therapies for cancer. The Italian biotech from Milan raised €10M in series A funding last year and is already getting ready for clinical trials. Genenta is developing a gene therapy platform for haematopoietic stem cells and wants to bring it to the clinic. Together with the San Raffaele Hospital and Scientific […] September 19, 2016 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 19 Sep 2016 Novozymes moves on Microbes in recent Acquisition The world’s leading producer of enzymes is making moves in the microbial world. Novozymes just acquired Organobalance, a German biotech specializing in microbes. Novozymes is a pillar of the Danish biotech scene and the world’s leading enzyme manufacturer. In 2000, it spun out of Novo Nordisk under the supervision of the World’s Best CEO, and […] September 19, 2016 - 2 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 19 Sep 2016 Abingworth launches UK Immuno-Oncology Startup with Seed Funding Just when we thought it couldn’t become any more intense, the field of immuno-oncology is heating up. VC giant Abingworth has seeded a new UK startup, GammaDelta Therapeutics, to bring its T cell therapy to the clinic. Abingworth, a huge British VC firm, has thrown its weight behind a new London-based immuno-oncology startup, GammaDelta Therapeutics. […] September 19, 2016 - 3 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 19 Sep 2016 How Tech Transfer brings Science from the Bench to the Bedside There are so many exciting discoveries in scientific research that could be used to cure, feed and fuel the world, but there is a giant gulf between science and business. Tech transfer aims to bridge the gap! I interviewed a number of experts in the field to tell you how. Since the first modern biotechnology […] September 19, 2016 - 6 minutesmins - By Marie Godar Share WhatsApp Twitter Linkedin Email
News and Trends 17 Sep 2016 This Slovenian Artist creates gorgeous Soundscapes from Underwater Worlds The annual Ars Electronica festival for digital art took Linz, Austria, last weekend and featured Slovenian bioartist Robertina Šebjanič in the Underworld bunker of its POSTCITY venue. She builds beautiful underwater gardens and translates them into sound, and one of them, Aurelia 1+Hz, won an Honorary Mention at the festival! Based in Ljubljana, Robertina explores living […] September 17, 2016 - 2 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 26 Jul 2016 What is Lithuania’s role in European Biotech? Since the days of the Soviet Union, Lithuania has always been considered as a leader in life sciences discoveries in Eastern Europe due to its infrastructure. But what about for Biotech? Nowadays, as a member of the NATO, the European Union, and Eurozone, Lithuania’s life science sector is growing around 20-25% annually; with special focus on […] July 26, 2016 - 2 minutesmins - By Dani Bancroft Share WhatsApp Twitter Linkedin Email
News and Trends 25 Jul 2016 Merck and Sigma-Aldrich: Together to solve the toughest problems in life science In late 2015, the life science business of Merck joined forces with Sigma-Aldrich, bringing together two major life science players and completing the largest acquisition in the history of Merck KGaA, a leading science and technology company based in Darmstadt, Germany. We met with Klaus-Reinhard Bischoff, Head of Global Research & Applied Solutions Commercial Area […] July 25, 2016 - 3 minutesmins - By Joachim Eeckhout Share WhatsApp Twitter Linkedin Email
News and Trends 23 Jun 2016 How did we grow from 0 to 40,000 Monthly Visitors in 18 Months? The first 18 months of our startup have been a marathon for us, where each new visitor was like one more kilometer to conquer. Growing a digital media is not an easy task, especially if you want to build a good reputation based on the quality of your content. In this article, I share the […] June 23, 2016 - 7 minutesmins - By Joachim Eeckhout Share WhatsApp Twitter Linkedin Email